Therapy of Niacin for Rheumatoid Arthritis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

January 3, 2027

Study Completion Date

June 15, 2027

Conditions
Rheumatoid Arthritis (RA)
Interventions
DRUG

niacin sustained release capsules

The first stage: the niacin group was given niacin sustained-release capsules for 3 months, and the control group was given placebo for 3 months. The second stage: Both groups were given niacin sustained-release capsules for 3 months. Dosage of niacin sustained-release capsules and placebo: 500mg once a day for week 1-4; The dose is 1000mg once a day for 5 to 12 weeks

DRUG

Placebo

The group was given oral placebo for 3 months in the first stage and niacin sustained-release capsules for 3 months in the second stage. Dosage of niacin sustained-release capsules and placebo: 500mg once a day for week 1-4; The dose is 1000mg once a day for 5 to 12 weeks.

All Listed Sponsors
lead

Peking University People's Hospital

OTHER